Table 1.
Reference | CN n = 21 | Path confirmed | FTD n = 47 | ||
---|---|---|---|---|---|
CN scans n = 120 | AD n = 48 | DLB n = 20 | |||
No. with scan primary diagnosis matches pathology (%) | 120 (100) | 19 (90) | 43 (90) | 14 (70) | 38 (81) |
No. of females (%) | 63 (53) | 14 (67) | 27 (56) | 7 (35) | 23 (49) |
Median age at scan, yr (min, max) | 76 (55, 90) | 84 (53, 99) | 76 (46, 96) | 74 (59, 89) | 59 (34, 84) |
Median age at death, yr (min, max)* | 89 (75, 99) | 89 (57, 103) | 81 (51, 103) | 78 (62, 93) | 67 (35, 90) |
Median time from scan to death, yr (min, max) | 7.6 (3.1, 11.4) | 4.0 (1.2, 10.5) | 5.4 (2.3, 12.4) | 4.4 (0.2, 8.0) | 3.7 (0.2, 9.0) |
Median education, yr (min, max) | 14 (8, 20) | 15 (8, 20) | 14 (8, 18) | 15 (8, 20) | 14 (8, 20) |
No. of APOE e4 carriers (%)† | 32 (27) | 5 (24) | 25 (54) | 8 (42) | 8 (27) |
Median MMSE (min, max) | 29 (24, 30) | 29 (25, 30) | 23 (11, 29) | 24 (15, 28) | 24 (2, 30) |
Median CDR sum of boxes (min, max) | 0.0 (0.0, 0.5) | 0.0 (0.0, 2.0) | 4.0 (0.5, 17.0) | 4.3 (1.5, 11.0) | 5.5 (0.5, 18.0) |
There were 33 patients from the control reference scan group that died.
There were 20 patients missing APOE genotyping.